SGLT2 inhibitors confer greater risk reductions for major adverse cardiovascular events in older adults with type 2 diabetes ...

Regardless of country-level income classification, medications for the secondary prevention of CVD remains underutilized and ...

A Boston-area biopharmaceutical firm has submitted a biologics license application to the FDA for its investigational, fully ...

Nearly 50% of women who utilized antidepressant prescriptions before conception discontinued use after pregnancy without ...

In this Healio Video Perspective from Hawaiian Eye 2025, Richard Small, CEO of Neurotech Pharmaceuticals, discusses the ...

In his 2025 to 2026 term as American Academy of Allergy, Asthma & Immunology president, Frank S. Virant, MD, FAAAAI, plans to ...

Undergraduate medical schools show “significant variation” in rheumatology training, with some students receiving as few as 4 ...

In this video, Marlise R. Luskin, MD, MSCE, highlights updates from two groups evaluating blinatumomab and ponatinib for the treatment of acute lymphoblastic leukemia.

Patients who traveled to high-volume centers for esophagectomy experienced better outcomes than those who sought treatment ...

A qualitative study yielded important insights about how patients, caregivers and clinicians define what truly is clinically ...

World Cancer Day will be observed Feb. 4.Union for International Cancer Control (UICC) created World Cancer Day in 2000 to ...

In a video interview, William K. Oh, MD, director of precision medicine at Yale Cancer Center and Smilow Cancer Hospital discusses the latest breakthroughs in advanced prostate cancer treatment.